APA (7th ed.) Citation

I, B., M, B., A, M., FF, R., J, W., D, M., . . . S, P. (2026). Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru®, vs an Oil-Based Formulation, Epidyolex®, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study. CNS drugs, 40(5), 709. https://doi.org/10.1007/s40263-026-01280-1

Chicago Style (17th ed.) Citation

I, Bendik, et al. "Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru®, Vs an Oil-Based Formulation, Epidyolex®, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study." CNS Drugs 40, no. 5 (2026): 709. https://doi.org/10.1007/s40263-026-01280-1.

MLA (9th ed.) Citation

I, Bendik, et al. "Comparative Pharmacokinetics and Safety of Cannabidiol in a Powder Formulation, CBtru®, Vs an Oil-Based Formulation, Epidyolex®, Under Fasted and Fed Conditions in Healthy Participants: A Randomized Open-Label Cross-Over Phase I Study." CNS Drugs, vol. 40, no. 5, 2026, p. 709, https://doi.org/10.1007/s40263-026-01280-1.